250 related articles for article (PubMed ID: 29301196)
1. Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.
Dagenais-Lussier X; Loucif H; Murira A; Laulhé X; Stäger S; Lamarre A; van Grevenynghe J
Viruses; 2017 Dec; 10(1):. PubMed ID: 29301196
[TBL] [Abstract][Full Text] [Related]
2. Confounding roles for type I interferons during bacterial and viral pathogenesis.
Carrero JA
Int Immunol; 2013 Dec; 25(12):663-9. PubMed ID: 24158954
[TBL] [Abstract][Full Text] [Related]
3. Type I Interferon in Chronic Virus Infection and Cancer.
Snell LM; McGaha TL; Brooks DG
Trends Immunol; 2017 Aug; 38(8):542-557. PubMed ID: 28579323
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
5. Blockade of chronic type I interferon signaling to control persistent LCMV infection.
Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG
Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528
[TBL] [Abstract][Full Text] [Related]
6. Type I interferon signaling, regulation and gene stimulation in chronic virus infection.
Lukhele S; Boukhaled GM; Brooks DG
Semin Immunol; 2019 Jun; 43():101277. PubMed ID: 31155227
[TBL] [Abstract][Full Text] [Related]
7. New insights into type I interferon and the immunopathogenesis of persistent viral infections.
Snell LM; Brooks DG
Curr Opin Immunol; 2015 Jun; 34():91-8. PubMed ID: 25771184
[TBL] [Abstract][Full Text] [Related]
8. Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System.
Berry CM
Cytokine Growth Factor Rev; 2016 Oct; 31():83-90. PubMed ID: 27544015
[TBL] [Abstract][Full Text] [Related]
9. Too much of a good thing: Sustained type 1 interferon signaling limits humoral responses to secondary viral infection.
Teijaro JR
Eur J Immunol; 2016 Feb; 46(2):300-2. PubMed ID: 26783074
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses.
Teijaro JR
Adv Immunol; 2016; 132():135-158. PubMed ID: 27769506
[TBL] [Abstract][Full Text] [Related]
11. Decoding the complexity of type I interferon to treat persistent viral infections.
Wilson EB; Brooks DG
Trends Microbiol; 2013 Dec; 21(12):634-40. PubMed ID: 24216022
[TBL] [Abstract][Full Text] [Related]
12. Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons.
Truong P; Heydari S; Garidou L; McGavern DB
J Immunol; 2009 Sep; 183(6):3895-905. PubMed ID: 19717517
[TBL] [Abstract][Full Text] [Related]
13. Type I interferons in viral control and immune regulation.
Teijaro JR
Curr Opin Virol; 2016 Feb; 16():31-40. PubMed ID: 26812607
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
[TBL] [Abstract][Full Text] [Related]
15. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
[TBL] [Abstract][Full Text] [Related]
16. Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis.
Huang Y; Dai H; Ke R
Front Immunol; 2019; 10():1736. PubMed ID: 31396233
[TBL] [Abstract][Full Text] [Related]
17. Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses.
Honke N; Shaabani N; Merches K; Gassa A; Kraft A; Ehrhardt K; Häussinger D; Löhning M; Dittmer U; Hengel H; Recher M; Lang PA; Lang KS
Eur J Immunol; 2016 Feb; 46(2):372-80. PubMed ID: 26507703
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding the role of type I interferons in systemic lupus erythematosus.
Crow MK
Curr Opin Rheumatol; 2014 Sep; 26(5):467-74. PubMed ID: 25010440
[TBL] [Abstract][Full Text] [Related]
19. Activation of endogenous type I IFN signaling contributes to persistent HCV infection.
Li Y; Li S; Duan X; Liu B; Yang C; Zeng P; McGilvray I; Chen L
Rev Med Virol; 2014 Sep; 24(5):332-42. PubMed ID: 24806972
[TBL] [Abstract][Full Text] [Related]
20. The unique regulation and functions of type III interferons in antiviral immunity.
Odendall C; Kagan JC
Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
